Editorial Board Member

Biography

Nano-formulations for cosmeceuticals and nutraceuticals derived from herbs, modified disulfide nano-biopolymers for colon-targeted drug delivery, and metabolomics-based drug discovery from natural products Dr. Vuanghao Lim is currently an Associate Professor in the Department of Toxicology at the Advanced Medical and Dental Institute (IPPT), Universiti Sains Malaysia. Throughout a distinguished career in academia and research, Dr. Lim has held prominent roles, including Visiting Professor at Xinxiang Medical University in Henan, China, and Research Advisor at Singapore’s Nan Yang Academy of Sciences. In 2017, he represented Malaysia as a fellow in the Community Solutions Program at the Botanical Research Institute of Texas. Expanding his academic pursuits, Dr. Lim was a Visiting Scholar at the University of North Texas and a Visiting Academic at The University of Queensland, Australia, in 2019. He has also served as a Visiting Scientist at Singapore University of Technology and Design, a Visiting Fellow at Khesar Gyalpo University of Medical Sciences of Bhutan, and a Visiting Lecturer at Mahasarakham University, Thailand, and Institut Teknologi Sepuluh Nopember, Indonesia. Additionally, he was appointed Adjunct Professor at Universitas Airlangga, Indonesia. In 2024, Dr. Lim was recognized as one of the World’s Top 2% Scientists. His research centers on nano-formulations for cosmeceuticals and nutraceuticals derived from herbs, modified disulfide nano-biopolymers for colon-targeted drug delivery, and metabolomics-based drug discovery from natural products. He has contributed to cutting-edge research in bioactive compounds, drug delivery, and the green synthesis of nanoparticles, including the development of environmentally friendly silver and zinc oxide nanoparticles for various biomedical applications. With a prolific portfolio, Dr. Lim has authored numerous publications in high- impact journals, notably within the top Q1 and Q2 categories, reflecting his innovative contributions to drug discovery and metabolomics.